UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

May 1, 2026

Conditions

Newly Diagnosed Type 1 Diabetes Mellitus

Interventions

DRUG

UCMSCs

Peripheral intravenous infusion of umbilical cord mesenchymal stem cells

DRUG

Placebo

Peripheral intravenous infusion of Placebo

Trial Locations (1)

RECRUITING

Shanghai Changzheng Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Changzheng Hospital

OTHER

NCT06407297 - UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes | Biotech Hunter | Biotech Hunter